{"Symbol": "ANTX", "AssetType": "Common Stock", "Name": "AN2 Therapeutics Inc", "Description": "Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.", "CIK": "1880438", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "1800 EL CAMINO REAL, MENLO PARK, CA, UNITED STATES, 94027", "OfficialSite": "https://www.an2therapeutics.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "29046100", "EBITDA": "None", "PERatio": "None", "PEGRatio": "None", "BookValue": "2.206", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-1.13", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.283", "ReturnOnEquityTTM": "-0.459", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-1.13", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "1", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "0", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "0.481", "EVToRevenue": "-", "EVToEBITDA": "-2.11", "Beta": "-0.032", "52WeekHigh": "1.55", "52WeekLow": "1", "50DayMovingAverage": "1.142", "200DayMovingAverage": "1.153", "SharesOutstanding": "27402000", "SharesFloat": "17702000", "PercentInsiders": "25.458", "PercentInstitutions": "39.472", "DividendDate": "None", "ExDividendDate": "None"}